首页>
美国卫生研究院文献>Neuro-Oncology
>Survival neurocognitive function and health-related quality of life outcomes after rituximab—methotrexate BCNU teniposide and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
【2h】
Survival neurocognitive function and health-related quality of life outcomes after rituximab—methotrexate BCNU teniposide and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
展开▼
机译:利妥昔单抗—甲氨蝶呤、BCNU、替尼泊苷和泼尼松龙治疗原发性 CNS 淋巴瘤后的生存率、神经认知功能和健康相关生活质量结局:HOVON 105/ALLG NHL 24 研究的最终结果